General Information of Drug (ID: DMIB6I1)

Drug Name
Arglabin Drug Info
Synonyms 84692-91-1; AC1LCSV4; SCHEMBL15527919; DTXSID30233687; ZINC6634471; ACN-035850
Cross-matching ID
PubChem CID
5574924
ChEBI ID
CHEMBL73228
CAS Number
CAS 84692-91-1
TTD Drug ID
D0A2AJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid hormone biosynthesis 2.50 0.00e+0 43/61 (70.49%) AKR1C1;CYP1B1;AKR1C2;...
Viral protein interaction with cytokine and cytokine re... 2.39 0.00e+0 84/100 (84%) CXCL5;CXCL8;CCL21;...
Ferroptosis 2.25 0.00e+0 36/41 (87.8%) HMOX1;GCLM;SLC7A11;...
Metabolism of xenobiotics by cytochrome P450 2.25 0.00e+0 49/77 (63.64%) AKR1C1;CYP1B1;ALDH3A1;...
Retinol metabolism 2.15 0.00e+0 41/68 (60.29%) UGT2B28;CYP3A5;UGT2B4;...
Bile secretion 2.15 0.00e+0 68/90 (75.56%) ABCC2;UGT2B28;ABCC3;...
Porphyrin and chlorophyll metabolism 2.13 0.00e+0 23/43 (53.49%) HMOX1;UGT2B28;UGT2B4;...
Folate biosynthesis 2.11 0.00e+0 23/26 (88.46%) AKR1B10;AKR1C3;SPR;...
Drug metabolism 2.07 0.00e+0 78/151 (51.66%) CES1;ALDH3A1;UGT2B28;...
Mineral absorption 2.03 2.33e-3 48/60 (80%) HMOX1;FTH1;STEAP1;...
Glutathione metabolism 2.02 2.12e-3 43/57 (75.44%) GPX2;GCLM;GSTA1;...
Tyrosine metabolism 2.02 1.94e-3 30/36 (83.33%) ALDH3A1;HPD;AOX1;...
IL-17 signaling pathway 2.02 1.80e-3 84/94 (89.36%) CXCL5;CXCL8;MMP9;...
Cytokine-cytokine receptor interaction 1.98 1.67e-3 246/295 (83.39%) CXCL5;CXCL8;CCL21;...
DNA replication 1.96 1.56e-3 34/36 (94.44%) SSBP1;POLE2;FEN1;...
Ubiquinone and other terpenoid-quinone biosynthesis 1.88 2.92e-3 9/11 (81.82%) NQO1;HPD;TAT
Arachidonic acid metabolism 1.88 2.75e-3 48/61 (78.69%) GPX2;CYP4F3;PTGDS;...
Tryptophan metabolism 1.84 5.19e-3 35/42 (83.33%) KYNU;KMO;CYP1B1;...
Phenylalanine metabolism 1.81 9.21e-3 14/17 (82.35%) ALDH3A1;PAH;HPD;...
Pentose and glucuronate interconversions 1.78 1.23e-2 17/34 (50%) AKR1B10;UGT2B28;UGDH;...
Fluid shear stress and atherosclerosis 1.77 1.50e-2 123/139 (88.49%) HMOX1;NQO1;SDC1;...
Selenocompound metabolism 1.76 1.49e-2 11/17 (64.71%) TXNRD1;PAPSS2;MTR;...
Ascorbate and aldarate metabolism 1.72 1.93e-2 15/30 (50%) UGT2B28;UGDH;UGT2B4;...
Proteasome 1.72 2.09e-2 44/46 (95.65%) PSMD11;PSMD2;PSMC2;...
Rheumatoid arthritis 1.70 2.52e-2 78/93 (83.87%) CXCL5;CXCL8;CXCL1;...
Intestinal immune network for IgA production 1.68 2.56e-2 38/48 (79.17%) TGFB1;CD40;CXCL12;...
Mismatch repair 1.67 2.98e-2 22/23 (95.65%) EXO1;SSBP1;RFC5;...
TNF signaling pathway 1.67 2.88e-2 103/112 (91.96%) CXCL5;MMP9;CXCL1;...
Carbohydrate digestion and absorption 1.65 3.02e-2 37/47 (78.72%) SLC2A2;SLC37A4;AKT1;...
Fatty acid degradation 1.62 3.38e-2 40/43 (93.02%) ACAA2;ALDH2;CPT1A;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 0.12uM - 10uM 6H, 24H, 48H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 6H, 24H, 48H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 6H, 24H, 48H
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 1.11uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H